Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3

Interventions

Letrozole 23Docetaxel 17Cyclophosphamide 13Zoledronic Acid 12Trastuzumab 12Anastrozole 12exemestane 11Tamoxifen 11Paclitaxel 11Capecitabine 10Fulvestrant 8Epirubicin 8pegfilgrastim 7Saline Solution 7Bupivacaine 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Sodium Chloride 6Filgrastim 6Carboplatin 6pegylated granulocyte colony-stimulating factor 5palbociclib 5Ropivacaine 5Dexmedetomidine 5Bevacizumab 5ribociclib 4eribulin 4Vinorelbine 4Tranexamic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Alloderm × Breast × Clear all
NCT02372305 2018-07-18

Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery

University of Arkansas

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT00872859 2017-05-18

The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial

University of Utah

Phase 4 Completed
128 enrolled
Breast

Breast Neoplasms

NCT01561287 2016-05-11

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

University of Kentucky

Phase 4 Completed
48 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡